RE:RE:RE:RE:Reality quips... Share price is always the sum of collected investor opinion, roadking08, no matter how that opinion has been influenced. This forum is too often not helpful.
One other important point - this BoD and management has had control for only 4 months, since late September. The argument can be made that the full vision for the advancement of Bioasis could only be started as of December 4th with the resignations of the last 3 long term directors.
Whining in front of this team or otherwise rubbing their faces in our history is wrong.
I cannot speak for the BoD or management in any way on this. Rather, it should be obvious to you all that the new BoD and management can not, should not and (I expect) will not accept any responsibility for that history.
It's wrong, irresponsible, optically damaging and, frankly, kinda weird and stupid to hold their feet to the fire on this.
Leave them alone. Expect professionals like this to run the company in ways similar to the worlds they come from, the pharma and academic worlds of extraordinary work ethics (they're all PhDs and MDs!!!), high personal accomplishment, secret skunkworks and almost perfect success rates. (Stagliano, 3 for 3 with deals; Radhakrishnan with an astonishing clinical record and still found time to master Russian; Deborah Rathjen, noted pharma corporate leader, so needed by Bioasis; Mark Day, experienced, working fool, fearless; Mei Mei Tian with unparalled BBB knowledge and experience; Chris Lowe, can you spell $; and a number of other scientists who are already hard at work.)
And none of them had anything to do with the last 7 years.
Get behind them.
jdstox